These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4391044)

  • 1. The effects of ICI 50172, propranolol, pronethalol and MJ 1999 on beta-receptors.
    Wale J; Pun LQ; Rand MJ
    Eur J Pharmacol; 1969 Oct; 8(1):25-35. PubMed ID: 4391044
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective blockade of adrenoceptive beta receptors in the heart.
    Dunlop D; Shanks RG
    Br J Pharmacol Chemother; 1968 Jan; 32(1):201-18. PubMed ID: 4384337
    [No Abstract]   [Full Text] [Related]  

  • 3. Beta-adrenoceptor blocking properties and cardioselectivity of M & B 17,803A.
    Basil B; Jordan R; Loveless AH; Maxwell DR
    Br J Pharmacol; 1973 Jun; 48(2):198-211. PubMed ID: 4147427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol, MJ 1999 and Ciba 39089 Ba in ouabain and adrenaline induced cardiac arrhythmias.
    Raper C; Wale J
    Eur J Pharmacol; 1968 Aug; 4(1):1-12. PubMed ID: 5680367
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative study of some cardiovascular effects of sotalol (MJ 1999) and propranolol.
    Aberg G; Dzedin T; Lundholm L; Olsson L; Svedmyr N
    Life Sci; 1969 Apr; 8(7):353-65. PubMed ID: 5769443
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies with LB 46, a new beta-receptor blocking drug.
    Lubawski I; Wale J
    Eur J Pharmacol; 1969; 6(3):345-8. PubMed ID: 5816392
    [No Abstract]   [Full Text] [Related]  

  • 7. The assessment of -adrenoceptor blocking potency and cardioselectivity in vitro and in vivo.
    Baird JR; Linnell J
    J Pharm Pharmacol; 1972 Nov; 24(11):880-5. PubMed ID: 4405651
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiarrhythmic effects of dichloroisoprenaline, H 56-28, ICI 50172, LB 46, MJ 1999 and propranolol on aconitine-induced atrial and ouabain-induced ventricular arrhythmias.
    Hashimoto K; Nakayama K; Oshima T; Kumakura S
    Experientia; 1971 Jun; 27(6):666-7. PubMed ID: 4397569
    [No Abstract]   [Full Text] [Related]  

  • 9. The actions of selective beta-receptor antagonists on the guinea pig trachea.
    Levy B; Wilkenfeld BE
    Eur J Pharmacol; 1970 Jul; 11(1):67-74. PubMed ID: 4393450
    [No Abstract]   [Full Text] [Related]  

  • 10. Sympathetic involvement in vagal escape and the effects of beta-receptor blocking drugs.
    Raper C; Wale J
    Eur J Pharmacol; 1969 Oct; 8(1):47-57. PubMed ID: 4391045
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the effects of propranolol and MJ 1999 on cardiac beta-adrenoceptors in man.
    Kofi Ekue JM; Lowe DC; Shanks RG
    Br J Pharmacol; 1970 May; 38(3):546-53. PubMed ID: 4392540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. General concepts in the use of beta-blockers: the relative roles of specific and unspecific effects.
    Brunner H; Hedwall PR; Meier M
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 269(2):219-31. PubMed ID: 4397722
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of the local anaesthetic-, "quinidine-like"- and adrenergic beta-blocking-activities of five beta-receptor antagonists.
    Davis WG
    J Pharm Pharmacol; 1970 Apr; 22(4):284-90. PubMed ID: 4392570
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of some properties of pronethalol and propranolol.
    Black JW; Duncan WA; Shanks RG
    Br J Pharmacol Chemother; 1965 Dec; 25(3):577-91. PubMed ID: 4380598
    [No Abstract]   [Full Text] [Related]  

  • 15. Combinations of alpha and beta adrenergic blockers in isolated guinea-pig atria.
    Krell RD; Patil PN
    J Pharmacol Exp Ther; 1969 Dec; 170(2):262-71. PubMed ID: 4391006
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular and beta-adrenergic blocking effects of timolol.
    Mouillé P; Schmitt H; Cheymol G; Gauter E
    Eur J Pharmacol; 1976 Feb; 35(2):235-43. PubMed ID: 2481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pressor action of beta blocking agents in rats.
    Regoli D
    Can J Physiol Pharmacol; 1970 Jul; 48(7):481-9. PubMed ID: 5430353
    [No Abstract]   [Full Text] [Related]  

  • 18. The pharmacolgy of 5-(2-t-butylamino-1-hydroxyethyl) salicylamide (ah 3474), a beta-adrenoreceptor blocking agent.
    Blackburn CH; Byrne LJ; Cullum VA; Farmer JB; Levy GP
    J Pharm Pharmacol; 1969 Aug; 21(8):488-97. PubMed ID: 4389710
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular and antiarrhythmic effects of 1-(4,5-dichloro-2-thienyl)-2-t-butylaminoethanol (QM-5119), a new beta-adrenergic blocking agent.
    Darias V; del Río J
    Arzneimittelforschung; 1974 Nov; 24(11):1756-9. PubMed ID: 4155633
    [No Abstract]   [Full Text] [Related]  

  • 20. [Beta-receptor-blocking agents and their current clinical significance].
    Deptalla H; Wiegershausen B
    Dtsch Gesundheitsw; 1968 Dec; 23(50):2353-63. PubMed ID: 4389656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.